Insulin knockout mice have extended survival but volatile blood glucose levels on leptin therapy

Endocrinology

Volumn 157, Issue 3, 2016, Pages 1007-1012

  Neumann, Ursula H ^a   Denroche, Heather C ^a   Mojibian, Majid ^a   Covey, Scott D ^a   Kieffer, Timothy J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; CHOLESTEROL; CORTICOSTERONE; FATTY ACID; GLUCOSE; INSULIN; INSULIN GLARGINE; LEPTIN; TRIACYLGLYCEROL; GLUCAGON; GLUCOSE BLOOD LEVEL; GLYCEROL; INS1 PROTEIN, MOUSE; INS2 PROTEIN, MOUSE; INSULIN RECEPTOR; PEPTIDE; S961 PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HORMONAL THERAPY; HYPERGLYCEMIA; HYPOGLYCEMIA; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM;

3-HYDROXYBUTYRIC ACID; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FATTY ACIDS; GLUCAGON; GLYCEROL; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; LEPTIN; MICE; MICE, KNOCKOUT; PEPTIDES; RECEPTOR, INSULIN; TRIGLYCERIDES;

EID: 84960538941     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1890     Document Type: Article

References (12)

1. Perry RJ, Zhang XM, Zhang D, et al. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med. 2014;20:759-763.
2. Fujikawa T, Berglund ED, Patel VR, et al. Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. Cell Metab. 2013;18:431-444.
3. Denroche HC, Levi J, Wideman RD, et al. Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes. 2011;60:1414-1423.
4. German JP, Thaler JP, Wisse BE, et al. Leptin activates a novel CNS mechanism for insulin-independent normalizationofsevere diabetic hyperglycemia. Endocrinology. 2011;152:394-404.
5. Wang MY, Chen L, Clark GO, et al. Leptin therapy in insulindeficient type I diabetes. Proc Natl Acad Sci USA. 2010;107:4813-4819.
6. German JP, Wisse BE, Thaler JP, et al. Leptin deficiency causes insulin resistance induced byuncontrolled diabetes. Diabetes. 2010;59:1626-1634.
7. Yu X, Park BH, Wang MY, Wang ZV, Unger RH. Making insulindeficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci USA. 2008;105:14070-14075.
8. Denroche HC, Kwon MM, Quong WL, et al. Leptin induces fasting hypoglycaemia in a mouse model of diabetes through the depletion of glycerol. Diabetologia. 2015;58:1100-1108.
9. Duvillié B, Cordonnier N, Deltour L, et al. Phenotypic alterations in insulin-deficient mutant mice. Proc Natl Acad Sci USA. 1997;94:5137-5140.
10. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes. 2011;60:391-397.
11. Fujikawa T, Chuang JC, Sakata I, Ramadori G, Coppari R. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci USA. 2010;107:17391-17396.
12. Morton GJ, Meek TH, Matsen ME, Schwartz MW. Evidence against hypothalamic-pituitary-adrenal axis suppression in the antidiabetic action of leptin. J Clin Invest. 2015; 2015.